Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

May 6, 2022

Heparin-Free Purge: Bicarbonate-Based Purge Solution

A heparin-free purge alternative, sodium-bicarbonate, is now approved for certain patients, enabling simpler anticoagulation management and reduced heparin-related risks.

April 5, 2022

Case Study: PCCS Care Pathway and Use of Impella 5.5® with SmartAssist® Heart Pump

A Heart Team approach and hemodynamic assessment led to timely and effective use of Impella 5.5 with SmartAssist for this patient with PCCS.

March 16, 2022

Acute on Chronic Heart Failure and Cardiogenic Shock

Claudius Mahr, DO, discusses outcome differences between patients with acute de novo cardiogenic shock and patients with chronic heart failure deteriorating to shock.

March 14, 2022

Right Heart Catheterization in Cardiogenic Shock Associated with Improved Outcomes

Zubair Shah, MD, explains how his research revealed improved outcomes in patients with cardiogenic shock receiving right heart catheterization.

February 22, 2022

IABP for Acute-On-Chronic Heart Failure Complicated by Cardiogenic Shock

Federico Pappalardo, MD, describes the role of IABP in the treatment of acute-on-chronic heart failure complicated by cardiogenic shock. 

February 3, 2022

Impella® Transport Considerations

Adam Gottula, MD, discusses considerations for optimizing patient care when transporting patients supported with Impella or other mechanical circulatory support devices.

February 2, 2022

Using Administrative/Payer Databases: Limitations and Utility

Chuck Simonton, MD, discusses the limitations of published papers that use administrative or payer databases as data sources and provides an AMI cardiogenic shock example.

January 24, 2022

Role of Echocardiography and Impella® in Cardiogenic Shock

Michael Galvin, BS, RDCS, discusses the role of echocardiography and Impella in cardiogenic shock.

December 7, 2021

Clinical Analysis of Impella® in High-Risk PCI

Alexandra Lansky, MD, discusses a propensity-adjusted population-based analysis of Impella in patients undergoing high-risk PCI from a large-scale claims dataset. 

November 8, 2021

TCT 2021: Primary Results from the OPTIMUM Registry

Adam Salisbury, MD, presents the primary results from the OPTIMUM Registry, a late breaker at TCT 2021.

November 5, 2021

TCT 2021: SCAI Shock Stage Update

Srihari Naidu, MD discusses updates to the SCAI shock stages at TCT 2021.

November 4, 2021

TCT 2021: Real World Evidence Leading to RECOVER IV

William O’Neill, MD, discusses the development of best practices for treating AMI cardiogenic shock leading to the RECOVER IV RCT.

November 4, 2021

TCT 2021: MCS During High-Risk PCI and PROTECT IV

Gregg Stone, MD, reviews evidence for the use of mechanical circulatory support during high-risk PCI and provides an overview of the PROTECT IV RCT.

November 3, 2021

Best Practices for Treating High-Risk PCI Patients

Jason Wollmuth, MD, discusses large-bore access and intravascular imaging best practices for treating high-risk PCI patients.

November 3, 2021

Improved Outcomes with Contemporary Practices in PROTECT III

Jeffrey Moses, MD, discusses the improved outcomes with contemporary practices seen in the PROTECT III study of Impella-supported high-risk PCI.

NPS-1674